The aim of our study was to identify differences in the time taken to achieve the minimum clinically important difference (MCID), substantial clinical benefit (SCB), and patient-acceptable symptom state (PASS) following primary hip arthroscopy for the treatment of femoroacetabular impingement syndrome (FAIS) among patients of different body mass index (BMI) categories.
We conducted a retrospective comparative study of hip arthroscopy patients with minimum 2-year follow-up. BMI categories were defined as normal (18.5 ≤ BMI < 25.0), overweight (25.0 ≤ BMI <30.0), or class I obese (30.0≤BMI<35.0). All subjects completed the modified Harris Hip Score (mHHS) prior to surgery and at 6 months, 1 year, and 2 years postoperative. MCID and SCB cutoffs were defined as pre-to-postoperative increases in mHHS by ≥8.2 and ≥19.8, respectively. PASS cutoff was set at postoperative mHHS ≥74. Time to achievement of each milestone was compared using the interval-censored EMICM algorithm. The effect of BMI was adjusted for age and sex using an interval-censored proportional hazards model.
285 patients were included in the analysis: 150 (52.6%) normal BMI, 99 (34.7%) overweight, and 36 (12.6%) obese. Obese patients had lower mHHS at baseline (P = .006) and at 2-year follow-up (P = .008). There were no significant intergroup differences in time to achievement for MCID (P = .92) or SCB (P = .69), but obese patients had longer time to PASS than normal BMI patients (P = .047). Multivariable analysis found obesity to be predictive of longer time to PASS (HR = .55; P = .007) but not MCID (HR = 0.91; P = .68) or SCB (HR = 1.06; P = .30).
Class I obesity is associated with delays in achieving a literature-defined PASS threshold after primary hip arthroscopy for FAIS. However, future research should consider incorporating PASS anchor questions to determine whether obesity truly carries a risk of delayed achievement of a satisfactory state of health as it pertains to the hip.
Level of Evidence
III, retrospective comparative study.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Arthroscopy
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- A review of important medical and surgical considerations for obese patients undergoing arthroscopic surgery.Phys Sportsmed. 2016; 44: 231-239
- Correlation of obesity with patient-reported outcomes and complications after hip arthroscopy.Arthroscopy. 2015; 31: 57-62
- Does obesity affect outcomes in hip arthroscopy? A matched-pair controlled study with minimum 2-year follow-up.Am J Sports Med. 2015; 43: 965-971
- The influence of body mass index on Outcomes After Hip Arthroscopy for Femoroacetabular Impingement Syndrome: Five-year results in 140 patients.Am J Sports Med. 2021; 49: 90-96
- The influence of body mass index on outcomes after hip arthroscopic surgery with capsular plication for the treatment of femoroacetabular impingement.Am J Sports Med. 2017; 45: 2303-2311
- Minimum five-year outcomes of hip arthroscopy for the treatment of femoroacetabular impingement and labral tears in patients with obesity: A match-controlled study.J Bone Joint Surg Am. 2018; 100: 965-973
- Outcome trends after hip arthroscopy for femoroacetabular impingement: When do patients improve?.Arthroscopy. 2019; 35: 3261-3270
- Time required to achieve minimal clinically important difference and substantial clinical benefit after arthroscopic treatment of femoroacetabular impingement.Am J Sports Med. 2018; 46: 2601-2606
- Minimal clinically important improvement/difference (MCII/MCID) and patient acceptable symptom state (PASS): what do these concepts mean?.Ann Rheum Dis. 2007; 66: iii40-41
- Parameters affecting baseline hip function in patients with cam-derived femoroacetabular impingement syndrome: data analysis from the German Cartilage Registry.J Orthop Traumatol. 2021; 22: 32
- Body mass index as a risk factor for 30-day postoperative complications in knee, hip, and shoulder arthroscopy.Arthroscopy. 2019; 35: 874-882.e873
- Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in Adults—The evidence report. National Institutes of Health.Obes Res. 1998; 6: 51S-209S
- Preoperative outcome scores are predictive of achieving the minimal clinically important difference after arthroscopic treatment of femoroacetabular impingement.Am J Sports Med. 2017; 45: 612-619
- Defining the "substantial clinical benefit" after arthroscopic treatment of femoroacetabular impingement.Am J Sports Med. 2017; 45: 1297-1303
- The patient-acceptable symptomatic state for the modified Harris hip score and hip outcome score among patients undergoing surgical treatment for femoroacetabular impingement.Am J Sports Med. 2015; 43: 1844-1849
- Arthroscopic cetabular labral repair versus labral debridement: Long-term survivorship and functional outcomes.Orthop J Sports Med. 2022; 1023259671221109012
- Hip arthroscopy in obese, a successful combination?.J Hip Preserv Surg. 2016; 3: 37-42
- Obesity is associated with less favorable outcomes following hip arthroscopic surgery: a systematic review and meta-analysis.Knee Surg Sports Traumatol Arthrosc. 2021; 29: 1483-1493
- Is there an association between preoperative expectations and patient-reported outcome after hip arthroscopy for femoroacetabular impingement syndrome?.Arthroscopy. 2019; 35: 3250-3258.e3251
Published online: February 19, 2023
Accepted: January 31, 2023
Received: June 28, 2022
Publication stageIn Press Journal Pre-Proof
The authors report the following potential conflicts of interest or sources of funding: T.Y. reports personal fees from Arthrex, outside the submitted work. Full ICMJE author disclosure forms are available for this article online, as supplementary material.
© 2023 by the Arthroscopy Association of North America